Literature DB >> 21495178

Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: developmental consequences of germline Ras/MAPK activation on myogenesis.

William E Tidyman1, Han S Lee, Katherine A Rauen.   

Abstract

Cardio-facio-cutaneous syndrome (CFC) and Costello syndrome (CS) are two of the more rare RASopathies caused by altered signal transduction of the Ras/mitogen-activated protein kinase (MAPK) pathway. All of the RASopathies exhibit some degree of hypotonia, but CS and CFC are more severe. To determine if individuals with CS and CFC have an underlying skeletal myopathy, we systematically evaluated skeletal muscle pathology in both conditions. We reviewed pathology reports from six individuals who had undergone a skeletal muscle biopsy, and we reviewed histology slides on two cases with CS and one case with CFC. All patients in the cohort had histopathologic findings, and two consistent abnormalities were identified. The first was the presence of abnormal muscle fiber size and variability, and the second was the presence of type 2 fiber predominance. Given the degree of hypotonia typically present in these patients, the overall architecture of the muscle was relatively normal, without showing indications of severe structural histopathology or metabolic abnormalities. Because the Ras/MAPK pathway is vital for skeletal myogenesis, we evaluated the effects of CS and CFC mutations on myogenesis using C2C12 myoblasts. All CS/CFC mutations inhibited myoblast differentiation as indicated by fewer myosin heavy chain expressing cells and a decrease in the number of myotubes as compared to controls. These findings indicate that CS and CFC may have a true myopathy related to an inherent dysregulation of skeletal myogenesis, which further expands our understanding of the consequences of germline Ras/MAPK mutations. 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21495178     DOI: 10.1002/ajmg.c.30298

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  13 in total

1.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

Review 2.  Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.

Authors:  Mary Ella M Pierpont; Pilar L Magoulas; Saleh Adi; Maria Ines Kavamura; Giovanni Neri; Jacqueline Noonan; Elizabeth I Pierpont; Kent Reinker; Amy E Roberts; Suma Shankar; Joseph Sullivan; Melinda Wolford; Brenda Conger; Molly Santa Cruz; Katherine A Rauen
Journal:  Pediatrics       Date:  2014-09-01       Impact factor: 7.124

3.  Muscle-derived extracellular signal-regulated kinases 1 and 2 are required for the maintenance of adult myofibers and their neuromuscular junctions.

Authors:  Bonnie Seaberg; Gabrielle Henslee; Shuo Wang; Ximena Paez-Colasante; Gary E Landreth; Mendell Rimer
Journal:  Mol Cell Biol       Date:  2015-01-20       Impact factor: 4.272

4.  NF1 is a critical regulator of muscle development and metabolism.

Authors:  Kate Sullivan; Jad El-Hoss; Kate G R Quinlan; Nikita Deo; Fleur Garton; Jane T C Seto; Marie Gdalevitch; Nigel Turner; Gregory J Cooney; Mateusz Kolanczyk; Kathryn N North; David G Little; Aaron Schindeler
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

5.  Kinetic mechanisms of mutation-dependent Harvey Ras activation and their relevance for the development of Costello syndrome.

Authors:  Michael Wey; Jungwoon Lee; Soon Seog Jeong; Jungho Kim; Jongyun Heo
Journal:  Biochemistry       Date:  2013-11-13       Impact factor: 3.162

Review 6.  Skeletal muscle and motor deficits in Neurofibromatosis Type 1.

Authors:  M A Summers; K G Quinlan; J M Payne; D G Little; K N North; A Schindeler
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

Review 7.  Fibroblast growth factor signaling in mammalian tooth development.

Authors:  Chun-Ying Li; Jan Prochazka; Alice F Goodwin; Ophir D Klein
Journal:  Odontology       Date:  2013-12-17       Impact factor: 2.885

8.  De novo deletion of chromosome 11q12.3 in monozygotic twins affected by Poland Syndrome.

Authors:  Carlotta Maria Vaccari; Maria Victoria Romanini; Ilaria Musante; Elisa Tassano; Stefania Gimelli; Maria Teresa Divizia; Michele Torre; Carmen Gloria Morovic; Margherita Lerone; Roberto Ravazzolo; Aldamaria Puliti
Journal:  BMC Med Genet       Date:  2014-05-30       Impact factor: 2.103

9.  Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex.

Authors:  Lei Xing; Rylan S Larsen; George Reed Bjorklund; Xiaoyan Li; Yaohong Wu; Benjamin D Philpot; William D Snider; Jason M Newbern
Journal:  Elife       Date:  2016-02-05       Impact factor: 8.140

10.  RNA-Seq Reveals miRNA Role Shifts in Seven Stages of Skeletal Muscles in Goat Fetuses and Kids.

Authors:  Yinghui Ling; Qi Zheng; Jing Jing; Menghua Sui; Lu Zhu; Yunsheng Li; Yunhai Zhang; Ya Liu; Fugui Fang; Xiaorong Zhang
Journal:  Front Genet       Date:  2020-07-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.